Burkholderia cepacia: Current clinical issues, environmental controversies and ethical dilemmas

European Respiratory Journal

Volumn 17, Issue 2, 2001, Pages 295-301

  Jones, A M ^a   Dodd, M E ^a   Webb, A K ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Agricultural industry; Burkholderia cepacia; Cystic fibrosis; Petrochemical industry; Pulmonary colonisation

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MINOCYCLINE; PESTICIDE; RIFAMPICIN;

AGRICULTURE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BIODEGRADATION; BURKHOLDERIA CEPACIA; CHRONIC GRANULOMATOUS DISEASE; CROSS INFECTION; CYSTIC FIBROSIS; DISEASE TRANSMISSION; ENVIRONMENTAL HEALTH; FATALITY; IMMUNE DEFICIENCY; LUNG; LUNG FUNCTION; MEDICAL ETHICS; MEDICAL LITERATURE; MEDICINE; MICROORGANISM; MULTIDRUG RESISTANCE; PATHOGENICITY; PETROCHEMICAL INDUSTRY; PLANT; PRIORITY JOURNAL;

BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CROSS INFECTION; CYSTIC FIBROSIS; DRUG RESISTANCE, MICROBIAL; HUMANS; LUNG DISEASES; PEST CONTROL, BIOLOGICAL; VIRULENCE;

EID: 0034948911     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.17202950     Document Type: Article

References (46)

1. Cystic Fibrosis Foundation, Cystic Fibrosis Patient Registry report
2. Should patients infected with Burkholderia cepacia undergo lung transplantation
3. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis
4. An epidemic of Burkholderia cepacia transmitted between patients with and without Cystic Fibrosis
5. The agricultural use of Burkholderia (Pseudomonas) cepacia: A threat to human health?
6. Sour skin, a bacterial rot of onion bulbs
7. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
8. Pseudomonas cepacia colonisation among patients with cystic fibrosis. A new opportunist
9. Pseudomonas cepacia: Decrease in colonisation in patients with cystic fibrosis
10. Ribotype analysis of Pseudomonas cepacia from CF treatment centres
11. Person-to-person transmission of Pseudomonas cepacia between patients with CF
12. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis
13. A physical genome map of the Burkholderia (Pseudomonas) cepacia type strain
14. Accuracy of four commercial systems for identification of Burkholderia cepacia and other Gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis
15. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a single new selective medium
16. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans species
17. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex
18. Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis
19. Pseudomonas cepacia: Fatal pulmonary infection in a patient with cystic fibrosis
20. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide
21. Relationship of Burkholderia cepacia to inflammatory markers in stable cystic fibrosis
22. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens
23. Lack of inducible nitric oxide synthase in bronchial epithelium: A possible mechanism of susceptibility to infection in cystic fibrosis
24. Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic
25. Pseudomonas cepacia in adult cystic fibrosis: Accelerated decline in lung function and increased mortality
26. The emergence of a highly transmissible lineage of cbl+ Burkholderia cepacia causing cystic fibrosis epidemics in North America and Britain
27. Linkage analysis of geographical and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping
28. Identification and characterisation of a novel marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis
29. Burkholderia cepacia: Medical taxonomic and ecological issues
30. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia
31. A statement on Burkholderia cepacia
32. Clinical outcome in relation to care in centres specialising in cystic fibrosis: Cross sectional survey
33. Multiple combination bacteriocidal testing for patients with cystic fibrosis infected with Burkholderia cepacia organisms
34. Bilateral lung transplantation for cystic fibrosis: The Toronto Lung Transplant Group
35. What is the good of health care?
36. Post transplant survival of cystic fibrosis patients infected with Pseudomonas cepacia
37. Infectious complications of lung transplantation: Impact of cystic fibrosis
38. Pseudomonas cepacia: An emerging pathogen in chronic granulomatous disease
39. Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia
40. Pseudomonas septicaemia in apparently healthy children
41. Burkholderia (Pseudomonas) cepacia as a cause of brain abscesses secondary to chronic suppurative otitis externa
42. Microbial contamination of antiseptics and disinfectants
43. An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution
44. An outbreak of Burkholderia cepacia with septicaemia on a cardiology ward
45. Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual
46. Burkholderia cepacia: Friend and foe